← FDA Drug Approvals (Drugs@FDA)

FLUDEOXYGLUCOSE F18

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUEEN HAMAMATSU PET · Approved 2015-08-31

Drug application

FDA Application #

ANDA203771

Application type

Abbreviated New Drug Application (Generic)

Brand name

FLUDEOXYGLUCOSE F18

Generic name

Fludeoxyglucose F-18

Active ingredients

FLUDEOXYGLUCOSE F-18

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

QUEEN HAMAMATSU PET

First approval

2015-08-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown